Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study

Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study
A personalized vaccine targeted to a patient’s own tumor cells yielded promising results in patients with recurrent advanced ovarian cancer, a Phase 1 pilot trial shows. The vaccine was safe, capable of triggering a broad anti-tumor immune response, and significantly delayed disease progression in patients responding to the therapy. The study “Personalized cancer vaccine effectively

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *